483
Pfizer Manufacturing Belgium NVPfizer Manufacturing Belgium NV – FDA 483, Jun 8, 2023
Record Details
An FDA inspection of Pfizer Manufacturing Belgium NV in Puurs-Sint-Amands, Belgium, identified one observation related to inadequate documentation of corrective and preventive action (CAPA) activities. Specifically, investigations into injector pen device complaints, such as blockages and underfills, lacked sufficient documentation. This indicates a deficiency in the firm's quality system regarding CAPA record-keeping.
View Company Profile
ID · a3ec07be-9ab6-4d43-be1a-7f2a3034c654
Other documents for Pfizer Manufacturing Belgium NV
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.